NHI-2, CAS [[1269802-97-2]]

Artikelnummer: MCE-HY-124309
Artikelname: NHI-2, CAS [[1269802-97-2]]
Artikelnummer: MCE-HY-124309
Hersteller Artikelnummer: HY-124309
Alternativnummer: MCE-HY-124309-10MG,MCE-HY-124309-25MG,MCE-HY-124309-5MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
NHI-2 is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 of 14.7 µM. NHI-2 shows selective for LDHA over LDHB (IC50 = 55.8 µM). NHI-2 is an efficient anti-glycolytic agent. NHI-2 enhances apoptosis, induces cell cycle arrest at S and G2 phases. NHI-2 has a broad spectrum anti-proliferative activity in cancer cells. NHI-2 affects extracellular acidification rate and ATP production. NHI-2 suppresses tumor growth in murine B78 melanoma tumor model[1][2].
Molekulargewicht: 335.28
Reinheit: 99.10
CAS Nummer: [1269802-97-2]
Formel: C17H12F3NO3
Target-Kategorie: Apoptosis,Lactate Dehydrogenase
Anwendungsbeschreibung: MCE Product type: Reference compound